Sanofi/Regeneron’s Dupixent could be first biologic approved for nasal polypsTrials of Sanofi and Regeneron’s drug Dupixent (dupilumab) have shown positive results for treating patients suffering from chronic Share XSanofi/Regeneron’s Dupixent could be first biologic approved for nasal polypshttps://pharmaphorum.com/news/sanofi-regenerons-dupixent-could-be-first-biologic-approved-for-nasal-polyps/
